iohexol has been researched along with Hepatic Failure in 2 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Full pharmacokinetic data (7-12 samples) from 172 patients receiving iohexol for measurement of their GFR (unstable and stable ICU patients, liver failure patients and kidney transplant patients) were split into development (n = 136) and validation (n = 36) datasets." | 8.12 | A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients. ( Åsberg, A; Barin-Le Guellec, C; Carrier, P; Destere, A; Ehrmann, S; Loustaud-Ratti, V; Marquet, P; Salmon Gandonnière, C; Woillard, JB, 2022) |
| "Full pharmacokinetic data (7-12 samples) from 172 patients receiving iohexol for measurement of their GFR (unstable and stable ICU patients, liver failure patients and kidney transplant patients) were split into development (n = 136) and validation (n = 36) datasets." | 4.12 | A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients. ( Åsberg, A; Barin-Le Guellec, C; Carrier, P; Destere, A; Ehrmann, S; Loustaud-Ratti, V; Marquet, P; Salmon Gandonnière, C; Woillard, JB, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Destere, A | 1 |
| Salmon Gandonnière, C | 1 |
| Åsberg, A | 1 |
| Loustaud-Ratti, V | 1 |
| Carrier, P | 1 |
| Ehrmann, S | 1 |
| Barin-Le Guellec, C | 1 |
| Marquet, P | 1 |
| Woillard, JB | 1 |
| Herlenius, G | 1 |
| Fistouris, J | 1 |
| Olausson, M | 1 |
| Felldin, M | 1 |
| Bäckman, L | 1 |
| Friman, S | 1 |
2 other studies available for iohexol and Hepatic Failure
| Article | Year |
|---|---|
A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients.
Topics: Bayes Theorem; Glomerular Filtration Rate; Humans; Intensive Care Units; Iohexol; Kidney Transplanta | 2022 |
Early renal function post-liver transplantation is predictive of progressive chronic kidney disease.
Topics: Chelating Agents; Contrast Media; Disease Progression; Edetic Acid; Female; Follow-Up Studies; Glome | 2008 |